• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征妇女血清中羧化不全骨钙素水平:与内分泌和代谢特征的体重依赖性关系。

Serum under-carboxylated osteocalcin levels in women with polycystic ovary syndrome: weight-dependent relationships with endocrine and metabolic traits.

机构信息

Endocrinology Chair, 6th Medical Sciences Department, "Iuliu Hatieganu" University of Medicine and Pharmacy, 3-5 Louis Pasteur, Cluj-Napoca, 400349, Romania.

出版信息

J Ovarian Res. 2013 Jan 22;6(1):4. doi: 10.1186/1757-2215-6-4.

DOI:10.1186/1757-2215-6-4
PMID:23339653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3557170/
Abstract

BACKGROUND

Under-carboxylated osteocalcin (ucOC), the precursor substrate of bone biomarker OC is a potent regulator of energy metabolism by promoting insulin production and adiponectin synthesis and decreasing fat stores. The aim of the present study was to point out the potential role of ucOC in the physiopathology of polycystic ovary syndrome (PCOS), a common disorder defined by the constellation of anovulation, insulinresistance, hyperinsulinemia, obesity and androgen excess.

METHODS

In this prospective case-control investigation, 78 young premenopausal women, i.e. 52 PCOS patients and 26 age- and body mass index (BMI)-matched healthy controls, were successively enrolled. Recruitment of PCOS patients was performed according to Androgen Excess-Polycystic Ovary Syndrome (AE-PCOS) Society 2006 criteria. All study participants were subjected to clinical examination, whole-body composition assessment and measurements of serum ucOC, OC (1-49), glucose and lipids, insulin, total testosterone (TT), estradiol, sex-hormone binding globulin (SHBG), high-sensitivity C-reactive protein (Hs-CRP) and β-CrossLaps.

RESULTS

BMI-stratified multivariate analysis revealed significantly higher ucOC levels in PCOS vs. controls in lean (p = 0.001) but not overweight and obese study participants (p = 0.456). Notably, a positive correlation between ucOC and TT (p = 0.018), calculated free testosterone (cFT, p = 0.028) and serum insulin (p = 0.036), respectively, was found to be confined to the lean analysis subgroup. Furthermore, in stepwise multiple regression models, β-CrossLaps and cFT were able to predict 46.71% of serum ucOC variability. (1-43/49)OC failed to be significantly associated to any PCOS trait.

CONCLUSIONS

Circulating ucOC concentration is related to key endocrine PCOS characteristics in a weight-dependent manner. Within the bone-pancreas loop, high ucOC may favor insulin release in lean hyperandrogenic women to compensate for impaired insulin sensitivity.

摘要

背景

非羧化骨钙素(ucOC)是骨生物标志物 OC 的前体底物,它通过促进胰岛素的产生和脂联素的合成,减少脂肪储存,是能量代谢的有力调节剂。本研究旨在指出 ucOC 在多囊卵巢综合征(PCOS)发病机制中的潜在作用,PCOS 是一种常见的疾病,其特征是排卵障碍、胰岛素抵抗、高胰岛素血症、肥胖和雄激素过多。

方法

在这项前瞻性病例对照研究中,连续纳入 78 名年轻绝经前妇女,即 52 名 PCOS 患者和 26 名年龄和体重指数(BMI)匹配的健康对照者。PCOS 患者的招募是根据雄激素过多-多囊卵巢综合征(AE-PCOS)学会 2006 年的标准进行的。所有研究参与者均接受了临床检查、全身成分评估以及血清 ucOC、OC(1-49)、葡萄糖和脂质、胰岛素、总睾酮(TT)、雌二醇、性激素结合球蛋白(SHBG)、高敏 C 反应蛋白(Hs-CRP)和β-胶原特殊序列的测定。

结果

BMI 分层多变量分析显示,在瘦体质(p=0.001)而非超重和肥胖的研究参与者中,PCOS 患者的 ucOC 水平显著升高(p=0.456)。值得注意的是,ucOC 与 TT(p=0.018)、计算游离睾酮(cFT,p=0.028)和血清胰岛素(p=0.036)之间的正相关关系仅局限于瘦体质亚组。此外,在逐步多元回归模型中,β-CrossLaps 和 cFT 能够预测 46.71%的血清 ucOC 变异性。(1-43/49)OC 与任何 PCOS 特征均无显著相关性。

结论

循环 ucOC 浓度与以体重依赖的方式与关键的内分泌 PCOS 特征相关。在骨-胰腺循环中,高 ucOC 可能有利于瘦高雄性激素女性胰岛素的释放,以代偿胰岛素敏感性的降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31bb/3557170/b9b0346b7051/1757-2215-6-4-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31bb/3557170/7fe965f7ffdc/1757-2215-6-4-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31bb/3557170/b9b0346b7051/1757-2215-6-4-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31bb/3557170/7fe965f7ffdc/1757-2215-6-4-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31bb/3557170/b9b0346b7051/1757-2215-6-4-2.jpg

相似文献

1
Serum under-carboxylated osteocalcin levels in women with polycystic ovary syndrome: weight-dependent relationships with endocrine and metabolic traits.多囊卵巢综合征妇女血清中羧化不全骨钙素水平:与内分泌和代谢特征的体重依赖性关系。
J Ovarian Res. 2013 Jan 22;6(1):4. doi: 10.1186/1757-2215-6-4.
2
Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters.多囊卵巢综合征女性的血清脂联素及其与临床、代谢和内分泌参数的关系。
J Endocrinol Invest. 2004 Jun;27(6):528-34. doi: 10.1007/BF03347474.
3
The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.多囊卵巢综合征和肥胖对绝经前女性血清促性腺激素和性激素浓度的独立影响。
Clin Endocrinol (Oxf). 1994 Oct;41(4):473-81. doi: 10.1111/j.1365-2265.1994.tb02578.x.
4
Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome.在患有多囊卵巢综合征的高雄激素女性中,体脂和胰岛素抵抗各自独立预测血清C反应蛋白升高。
Eur J Endocrinol. 2009 Nov;161(5):737-45. doi: 10.1530/EJE-09-0379. Epub 2009 Aug 27.
5
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.美国临床内分泌医师协会、美国内分泌学会以及雄激素过多与多囊卵巢综合征协会疾病状态临床综述:多囊卵巢综合征评估与治疗最佳实践指南——第1部分。
Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC.
6
High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).印度患有多囊卵巢综合征(PCOS)的青春期女性的高敏C反应蛋白(hs-CRP)水平及其与多囊卵巢综合征各组分的关系。
Gynecol Endocrinol. 2014 Nov;30(11):781-4. doi: 10.3109/09513590.2014.924099. Epub 2014 Aug 19.
7
Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.多囊卵巢综合征的瘦型和肥胖型女性的胰岛素、生长激素及促黄体生成素轴:共同特征与不同特征
J Clin Endocrinol Metab. 1996 Aug;81(8):2854-64. doi: 10.1210/jcem.81.8.8768842.
8
Osteocalcin levels on oral glucose load in women being investigated for polycystic ovary syndrome.对疑似多囊卵巢综合征的女性进行口服葡萄糖负荷试验时的骨钙素水平。
Endocr Pract. 2014 Jan;20(1):5-14. doi: 10.4158/EP13110.OR.
9
Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.血脂异常与多囊卵巢女性的胰岛素抵抗有关。
Clin Endocrinol (Oxf). 1996 Mar;44(3):277-84. doi: 10.1046/j.1365-2265.1996.674495.x.
10
Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome.确定雄激素标志物在多囊卵巢综合征评估中的临界值。
Malays J Pathol. 2018 Apr;40(1):33-39.

引用本文的文献

1
The correlations between serum bone biomarkers and those related to metabolic and hormonal profile, low-grade inflammation and redox balance, in lean and overweight PCOS adolescent girls.瘦型和超重型多囊卵巢综合征青春期女孩血清骨生物标志物与代谢、激素水平、低度炎症及氧化还原平衡相关指标之间的相关性。
Front Nutr. 2025 Jul 7;12:1477992. doi: 10.3389/fnut.2025.1477992. eCollection 2025.
2
Vitamin D, Bone Metabolism, and Fracture Risk in Polycystic Ovary Syndrome.多囊卵巢综合征中的维生素D、骨代谢与骨折风险
Metabolites. 2021 Feb 18;11(2):116. doi: 10.3390/metabo11020116.
3
Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights.

本文引用的文献

1
Ethinylestradiol30μg-drospirenone and metformin: could this combination improve endothelial dysfunction in polycystic ovary syndrome?屈螺酮炔雌醇 30μg-地屈孕酮与二甲双胍:联合应用可否改善多囊卵巢综合征患者的内皮功能障碍?
BMC Endocr Disord. 2012 Jun 19;12:9. doi: 10.1186/1472-6823-12-9.
2
Total and undercarboxylated osteocalcin predict changes in insulin sensitivity and β cell function in elderly men at high cardiovascular risk.总骨钙素和非羧化骨钙素可预测心血管高危老年男性胰岛素敏感性和β细胞功能的变化。
Am J Clin Nutr. 2012 Jan;95(1):249-55. doi: 10.3945/ajcn.111.016642. Epub 2011 Dec 14.
3
Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
多囊卵巢综合征中的氧化应激和低度炎症:争议与新见解。
Int J Mol Sci. 2021 Feb 7;22(4):1667. doi: 10.3390/ijms22041667.
4
PHOSPHO1 is a skeletal regulator of insulin resistance and obesity.PHOSPHO1 是胰岛素抵抗和肥胖的骨骼调节因子。
BMC Biol. 2020 Oct 22;18(1):149. doi: 10.1186/s12915-020-00880-7.
5
The Relationship Between Polycystic Ovarian Syndrome, Periodontal Disease, and Osteoporosis.多囊卵巢综合征、牙周病和骨质疏松症之间的关系。
Reprod Sci. 2021 Apr;28(4):950-962. doi: 10.1007/s43032-020-00310-7. Epub 2020 Sep 10.
6
Phospholipase C-related but catalytically inactive proteins regulate ovarian follicle development.磷脂酶C相关但催化无活性的蛋白调节卵巢卵泡发育。
J Biol Chem. 2017 May 19;292(20):8369-8380. doi: 10.1074/jbc.M116.759928. Epub 2017 Mar 30.
7
Age and menopausal status affect osteoprotegerin and osteocalcin levels in women differently, irrespective of thyroid function.年龄和绝经状态对女性骨保护素和骨钙素水平的影响不同,与甲状腺功能无关。
Clin Med Insights Endocrinol Diabetes. 2014 Jul 29;7:19-24. doi: 10.4137/CMED.S15466. eCollection 2014.
胰岛素抵抗与多囊卵巢综合征不同表型的内分泌特征:一项前瞻性研究。
Hum Reprod. 2012 Feb;27(2):541-9. doi: 10.1093/humrep/der418. Epub 2011 Dec 5.
4
Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study).未羧化骨钙素的变化与体重、体脂肪量和脂联素的变化相关:甲状旁腺激素(1-84)或阿仑膦酸钠治疗绝经后骨质疏松症妇女(PaTH 研究)。
J Clin Endocrinol Metab. 2011 Dec;96(12):E1982-9. doi: 10.1210/jc.2011-0587. Epub 2011 Oct 12.
5
Adiponectin and leptin serum levels in osteoporotic postmenopausal women treated with raloxifene or alendronate.绝经后骨质疏松症患者接受雷洛昔芬或阿仑膦酸钠治疗后血清脂联素和瘦素水平的变化。
Menopause. 2012 Feb;19(2):172-7. doi: 10.1097/gme.0b013e31822815c0.
6
Relationship of testosterone and osteocalcin levels during growth.睾酮和骨钙素水平在生长过程中的关系。
J Bone Miner Res. 2011 Sep;26(9):2212-6. doi: 10.1002/jbmr.421.
7
Androgens modulate osteocalcin release by human visceral adipose tissue.雄激素调节人体内脏脂肪组织中骨钙素的释放。
Clin Endocrinol (Oxf). 2011 Jul;75(1):64-9. doi: 10.1111/j.1365-2265.2011.03997.x.
8
Endocrine regulation of male fertility by the skeleton.骨骼对男性生育力的内分泌调控。
Cell. 2011 Mar 4;144(5):796-809. doi: 10.1016/j.cell.2011.02.004. Epub 2011 Feb 17.
9
Obesity reduces bone density associated with activation of PPARγ and suppression of Wnt/β-catenin in rapidly growing male rats.肥胖症降低了快速生长的雄性大鼠的骨密度,这与 PPARγ 的激活和 Wnt/β-连环蛋白的抑制有关。
PLoS One. 2010 Oct 28;5(10):e13704. doi: 10.1371/journal.pone.0013704.
10
Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction.多囊卵巢综合征患者循环骨保护素和核因子κB 配体可溶性受体激活物:与胰岛素抵抗和血管内皮功能障碍的关系。
Eur J Endocrinol. 2011 Jan;164(1):61-8. doi: 10.1530/EJE-10-0720. Epub 2010 Oct 25.